Cargando…
Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
The coronavirus disease 2019 (COVID-19) has become a global pandemic since December 2019. Although COVID-19 primarily affects the respiratory systems, it has become abundantly clear that it involves multiple organs including the heart, kidney, skin, and brain. Neuro-ophthalmic signs and anterior seg...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493986/ https://www.ncbi.nlm.nih.gov/pubmed/34703738 http://dx.doi.org/10.4103/tjo.tjo_30_21 |
_version_ | 1784579225243615232 |
---|---|
author | Sutandi, Nathania Lee, Felix |
author_facet | Sutandi, Nathania Lee, Felix |
author_sort | Sutandi, Nathania |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) has become a global pandemic since December 2019. Although COVID-19 primarily affects the respiratory systems, it has become abundantly clear that it involves multiple organs including the heart, kidney, skin, and brain. Neuro-ophthalmic signs and anterior segment inflammation of the eyes were documented in COVID-19 patients recently. Small but growing number of literatures has also reported the cases of new onset vitreoretinal disorders related to COVID-19 infection. A comprehensive search from four online databases was done. Findings show vitreoretinal involvement in COVID-19 patients including the central retinal vein occlusion, central retinal artery occlusion, reactivation of previous uveitis, chorioretinitis, macular hemorrhage, acute macular neuroretinopathy, paracentral acute middle maculopathy, vitritis with outer retinal abnormalities, varicella zoster virus-related acute retinal necrosis in immunocompromised patient, and other posterior segment pathological changes. The hypotheses for potential pathogenesis of these manifestations are direct viral ocular infection and thromboembolic complications secondary to the hyperinflammatory response. This is the first review article, which provides an overview of current evidence regarding the vitreoretinal manifestations in COVID-19 patients. |
format | Online Article Text |
id | pubmed-8493986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-84939862021-10-25 Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far Sutandi, Nathania Lee, Felix Taiwan J Ophthalmol Review Article The coronavirus disease 2019 (COVID-19) has become a global pandemic since December 2019. Although COVID-19 primarily affects the respiratory systems, it has become abundantly clear that it involves multiple organs including the heart, kidney, skin, and brain. Neuro-ophthalmic signs and anterior segment inflammation of the eyes were documented in COVID-19 patients recently. Small but growing number of literatures has also reported the cases of new onset vitreoretinal disorders related to COVID-19 infection. A comprehensive search from four online databases was done. Findings show vitreoretinal involvement in COVID-19 patients including the central retinal vein occlusion, central retinal artery occlusion, reactivation of previous uveitis, chorioretinitis, macular hemorrhage, acute macular neuroretinopathy, paracentral acute middle maculopathy, vitritis with outer retinal abnormalities, varicella zoster virus-related acute retinal necrosis in immunocompromised patient, and other posterior segment pathological changes. The hypotheses for potential pathogenesis of these manifestations are direct viral ocular infection and thromboembolic complications secondary to the hyperinflammatory response. This is the first review article, which provides an overview of current evidence regarding the vitreoretinal manifestations in COVID-19 patients. Wolters Kluwer - Medknow 2021-08-28 /pmc/articles/PMC8493986/ /pubmed/34703738 http://dx.doi.org/10.4103/tjo.tjo_30_21 Text en Copyright: © 2021 Taiwan J Ophthalmol https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Sutandi, Nathania Lee, Felix Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far |
title | Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far |
title_full | Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far |
title_fullStr | Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far |
title_full_unstemmed | Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far |
title_short | Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far |
title_sort | vitreoretinal abnormalities in corona virus disease 2019 patients: what we know so far |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493986/ https://www.ncbi.nlm.nih.gov/pubmed/34703738 http://dx.doi.org/10.4103/tjo.tjo_30_21 |
work_keys_str_mv | AT sutandinathania vitreoretinalabnormalitiesincoronavirusdisease2019patientswhatweknowsofar AT leefelix vitreoretinalabnormalitiesincoronavirusdisease2019patientswhatweknowsofar |